Literature DB >> 17453930

The non-O157 shiga-toxigenic (verocytotoxigenic) Escherichia coli; under-rated pathogens.

Karl A Bettelheim1.   

Abstract

Following a brief review of the ecology of Escherichia coli in general, the role of Shiga-Toxigenic (Verocytotoxigenic) E. coli (STEC) as pathogens is addressed. While STEC belonging to the serogroup O157 have been extensively studied and shown to be involved in many cases and outbreaks of human disease, the importance of STEC belonging to other serogroups has not been recognized as much. This review addresses the problems associated with these pathogens, demonstrating that increasing the awareness of them is a major part of the problem. This review then demonstrates how widespread isolations especially from food animals and human disease have been, discussing in particular STEC belonging to serogroups O8, O26, O103, O111, O113 and O128. The animal host-specificity of these STEC is also reviewed. In conclusion some methods of improving isolation of these pathogens is addressed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17453930     DOI: 10.1080/10408410601172172

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  91 in total

Review 1.  Molecular mechanisms that mediate colonization of Shiga toxin-producing Escherichia coli strains.

Authors:  Mauricio J Farfan; Alfredo G Torres
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Non-O157 verotoxigenic Escherichia coli and beef: a Canadian perspective.

Authors:  Alexander Gill; Colin O Gill
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

3.  Identification of Escherichia coli O157 by using a novel colorimetric detection method with DNA microarrays.

Authors:  Beatriz Quiñones; Michelle S Swimley; Amber W Taylor; Erica D Dawson
Journal:  Foodborne Pathog Dis       Date:  2011-02-02       Impact factor: 3.171

4.  Phylogenetic analysis of non-O157 Shiga toxin-producing Escherichia coli strains by whole-genome sequencing.

Authors:  Wenting Ju; Guojie Cao; Lydia Rump; Errol Strain; Yan Luo; Ruth Timme; Marc Allard; Shaohua Zhao; Eric Brown; Jianghong Meng
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

5.  Comparison of Enrichment Broths for Supporting Growth of Shiga Toxin-Producing Escherichia coli.

Authors:  Zachary R Stromberg; Gentry L Lewis; David B Marx; Rodney A Moxley
Journal:  Curr Microbiol       Date:  2015-04-28       Impact factor: 2.188

6.  Production of verotoxin and distribution of O islands 122 and 43/48 among verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans.

Authors:  Musafiri Karama; Roger P Johnson; Robert Holtslander; Carlton L Gyles
Journal:  Appl Environ Microbiol       Date:  2008-11-07       Impact factor: 4.792

7.  Presence and characterization of shiga toxin-producing Escherichia coli and other potentially diarrheagenic E. coli strains in retail meats.

Authors:  Xiaodong Xia; Jianghong Meng; Patrick F McDermott; Sherry Ayers; Karen Blickenstaff; Thu-Thuy Tran; Jason Abbott; Jie Zheng; Shaohua Zhao
Journal:  Appl Environ Microbiol       Date:  2010-01-15       Impact factor: 4.792

8.  Distribution of pathogenicity islands OI-122, OI-43/48, and OI-57 and a high-pathogenicity island in Shiga toxin-producing Escherichia coli.

Authors:  Wenting Ju; Jinling Shen; Magaly Toro; Shaohua Zhao; Jianghong Meng
Journal:  Appl Environ Microbiol       Date:  2013-03-22       Impact factor: 4.792

9.  Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes.

Authors:  Chih-Chi Andrew Hu; Stephanie K Dougan; Sebastian Virreira Winter; Adrienne W Paton; James C Paton; Hidde L Ploegh
Journal:  J Exp Med       Date:  2009-10-06       Impact factor: 14.307

10.  Phylogeny and disease association of Shiga toxin-producing Escherichia coli O91.

Authors:  Alexander Mellmann; Angelika Fruth; Alexander W Friedrich; Lothar H Wieler; Dag Harmsen; Dirk Werber; Barbara Middendorf; Martina Bielaszewska; Helge Karch
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.